BMC Medical Co Ltd
SZSE:301367
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BMC Medical Co Ltd
SZSE:301367
|
CN |
Balance Sheet
Balance Sheet Decomposition
BMC Medical Co Ltd
BMC Medical Co Ltd
Balance Sheet
BMC Medical Co Ltd
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
32
|
218
|
114
|
356
|
669
|
466
|
|
| Cash |
28
|
218
|
114
|
356
|
669
|
466
|
|
| Cash Equivalents |
4
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
61
|
124
|
295
|
2 160
|
1 853
|
2 294
|
|
| Total Receivables |
57
|
40
|
56
|
116
|
136
|
201
|
|
| Accounts Receivables |
45
|
28
|
24
|
93
|
109
|
186
|
|
| Other Receivables |
12
|
12
|
32
|
23
|
27
|
15
|
|
| Inventory |
27
|
47
|
117
|
203
|
118
|
102
|
|
| Other Current Assets |
2
|
6
|
7
|
14
|
16
|
72
|
|
| Total Current Assets |
180
|
435
|
589
|
2 849
|
2 791
|
3 136
|
|
| PP&E Net |
5
|
10
|
17
|
48
|
60
|
47
|
|
| PP&E Gross |
5
|
10
|
17
|
48
|
60
|
47
|
|
| Accumulated Depreciation |
11
|
13
|
20
|
23
|
37
|
57
|
|
| Intangible Assets |
3
|
3
|
3
|
8
|
6
|
6
|
|
| Long-Term Investments |
1
|
2
|
5
|
4
|
43
|
214
|
|
| Other Long-Term Assets |
9
|
9
|
10
|
18
|
19
|
22
|
|
| Total Assets |
199
N/A
|
460
+131%
|
624
+36%
|
2 927
+369%
|
2 919
0%
|
3 425
+17%
|
|
| Liabilities | |||||||
| Accounts Payable |
21
|
29
|
69
|
103
|
40
|
86
|
|
| Accrued Liabilities |
13
|
25
|
25
|
57
|
29
|
33
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
385
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
2
|
4
|
10
|
10
|
|
| Other Current Liabilities |
10
|
30
|
33
|
125
|
33
|
64
|
|
| Total Current Liabilities |
43
|
84
|
128
|
289
|
112
|
579
|
|
| Long-Term Debt |
0
|
0
|
3
|
17
|
16
|
8
|
|
| Deferred Income Tax |
0
|
0
|
0
|
2
|
1
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
7
|
8
|
9
|
|
| Other Liabilities |
1
|
2
|
1
|
1
|
2
|
0
|
|
| Total Liabilities |
45
N/A
|
86
+93%
|
132
+54%
|
317
+139%
|
139
-56%
|
597
+328%
|
|
| Equity | |||||||
| Common Stock |
3
|
48
|
48
|
64
|
64
|
90
|
|
| Retained Earnings |
60
|
276
|
393
|
773
|
942
|
1 034
|
|
| Additional Paid In Capital |
92
|
51
|
51
|
1 773
|
1 773
|
1 747
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
42
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
155
N/A
|
374
+142%
|
491
+31%
|
2 610
+431%
|
2 779
+6%
|
2 828
+2%
|
|
| Total Liabilities & Equity |
199
N/A
|
460
+131%
|
624
+36%
|
2 927
+369%
|
2 919
0%
|
3 425
+17%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
64
|
64
|
90
|
90
|
90
|
89
|
|